Skip to main content

Table 2 Levels of eosinophils (cells/mm2) and abundance (score) for smooth muscle proteins, periostin, and keratins at baseline (T0) and after 36 months of anti-IgE treatment (T36)

From: Galectin-3: an early predictive biomarker of modulation of airway remodeling in patients with severe asthma treated with omalizumab for 36 months

  OR1 OR2 OR3 OR4 NOR1 NOR2 NOR3 NOR4
Eosinophils
 T0 19 31 58 115 0 10 10 9
 T36 3 9 4 5 11 3 20 27
Smooth muscle proteins
 T0 288 80 198 494 0 0 20 0
 T36 10 20 0 0 168 0 30 98
Periostin
 T0 30 160 130 150 0 30 120 0
 T36 0 0 0 0 20 0 106 20
Keratins
 T0 1990 1902 1630 2047 1404 1910 1892 1676
 T36 574 276 100 266 2106 40 1330 1400
Galectin-3
 T0 10 10 30 20 0 0 0 0
 T36 0 0 0 0 0 0 0 0
  1. Increased values (or substantially unchanged) at T36 compared to T0 are reported in italic. For more details about available proteins see Additional file 2